Lv51
1500 积分 2025-07-08 加入
Correction to: Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR)
7天前
已关闭
Win Ratio Method for Hierarchical Composite Outcomes in Randomized Clinical Trials
7天前
已完结
The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
8天前
已完结
Synergistic Interactions Among Fatigue, Sleep Disturbance, and Depression in Women With Breast Cancer: A Cross-Sectional Study
10天前
已完结
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer
25天前
已完结
Acute Change in Perceived Cognitive Performance Across Different Age Groups Following First Chemotherapy Infusion in Female Patients With Breast Cancer
25天前
已完结
Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study
25天前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
25天前
已完结
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
26天前
已完结
Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve
26天前
已完结
皖公网安备34019202002308
